PRIME MEDICINE INC (PRME) Stock Earnings & Estimates
USA - NASDAQ:PRME - US74168J1016 - Common Stock
5.12 USD
+0.47 (+10.11%)
5.15 USD
+0.03 (+0.59%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.983M | 8.34M 179.58% | 2.997M -64.06% | 20.09M 570.34% | 1.496M -92.55% | 5.977M 299.53% | 19.722M 229.96% | 149.16M 656.31% | 520.47M 248.93% | |||
| EBITDA YoY % growth | -114.32M -36.26% | -200.139M -75.07% | -196.339M 1.90% | -172.412M 12.19% | -147.573M 14.41% | -162.617M -10.19% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -116.54M -37.97% | -204.792M -75.73% | -202.467M 1.14% | -187.074M 7.60% | -164.183M 12.24% | -177.006M -7.81% | -194.219M -9.72% | -199.892M -2.92% | -185.71M 7.09% | -77.833M 58.09% | 207.19M 366.20% | |
| Operating Margin | N/A | N/A | -6,787.36% | -2,243.09% | -5,478.26% | -881.06% | -12,982.58% | -3,344.35% | -941.64% | -52.18% | 39.81% | |
| EPS YoY % growth | N/A | -2.18 26.93% | -1.65 24.31% | -1.22 26.14% | -0.94 22.77% | -0.90 4.36% | -0.83 7.77% | -0.76 8.78% | -0.68 10.44% | -0.33 51.38% | 0.71 316.52% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.26 41.35% | -0.21 32.58% | -0.24 38.86% | -0.25 39.67% | -0.28 -7.51% | -0.29 -36.98% | -0.29 -18.87% | -0.31 -25.77% | -0.31 -13.24% | -0.33 -14.01% | -0.35 -22.11% | -0.38 -23.61% |
| Revenue Q2Q % growth | 1.047M 400.96% | 3.553M 62.76% | -100.00% | 11.475M 929.15% | -100.00% | -100.00% | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -41.625M 16.45% | -33.283M 12.63% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -43.06M 20.60% | -37.155M 15.98% | -21.675M 58.63% | -27.285M 48.88% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.41 10.87% | -0.37 | -0.04 | -10.55% |
| Q1 2025 Q2Q % growth | -0.40 9.09% | -0.33 | -0.07 | -22.51% |
| Q4 2024 Q2Q % growth | -0.31 56.94% | -0.40 | 0.09 | 22.47% |
| Q3 2024 Q2Q % growth | -0.44 20.00% | -0.40 | -0.04 | -9.16% |
| Q2 2024 Q2Q % growth | -0.46 2.13% | -0.41 | -0.05 | -11.84% |
| Q1 2024 Q2Q % growth | -0.44 | -0.48 | 0.04 | 8.86% |
| Q4 2023 Q2Q % growth | -0.72 -28.57% | -0.52 | -0.20 | -38.48% |
| Q3 2023 Q2Q % growth | -0.55 | -0.47 | -0.08 | -17.22% |
| Q2 2023 Q2Q % growth | -0.47 | -0.43 | -0.04 | -8.85% |
| Q1 2023 Q2Q % growth | -0.44 | -0.42 | -0.02 | -4.20% |
| Q4 2022 Q2Q % growth | -0.56 | -0.67 | 0.11 | 15.86% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.115M | 1.53M | -415K | -27.12% |
| Q1 2025 Q2Q % growth | 1.454M 146.02% | 1.07M | 384K | 35.89% |
| Q4 2024 Q2Q % growth | 2.183M | 293.25K | 1.89M | 644.42% |
| Q3 2024 Q2Q % growth | 209K | 7.987M | -7.778M | -97.38% |
| Q2 2024 Q2Q % growth | 1.663M | -1.663M | -100.00% | |
| Q1 2024 Q2Q % growth | 591K | 165.75K | 425.25K | 256.56% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.64% | 25.95% | 7.83% | 8.25% |
| Revenue | -3.86% | 1952.94% | 23.21% | 36.97% |